Consistent with the immunophenotypic profile of low-grade malignant fibrosarcoma, only Vimentin is expressed in immunohistochemistry; SMA may show positive expression in instances of myofibroblastic differentiation; Desmin, CK, EMA, and CD34 were non-reactive. Here, SMN1 is linked to fibrosarcoma.